share_log

Wells Fargo Upgrades Celldex Therapeutics to Equal-Weight, Announces $27 Price Target

Wells Fargo Upgrades Celldex Therapeutics to Equal-Weight, Announces $27 Price Target

富國銀行將Celldex Therapeutics上調至同等權重,宣佈目標股價27美元
Benzinga ·  2023/11/10 06:27

Wells Fargo analyst Derek Archila upgrades Celldex Therapeutics (NASDAQ:CLDX) from Underweight to Equal-Weight and announces $27 price target.

富國銀行分析師德里克·阿奇拉將Celldex Therapeutics(納斯達克股票代碼:CLDX)從減持上調至同等權重,並宣佈了27美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論